Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

5.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

7.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
The Ras Gene02:38

The Ras Gene

6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive N-glycosylation profiling of recombinant spike S1 protein from the wild-type SARS-CoV-2 and its variants.

Frontiers in immunology·2025
Same author

[Chemical analysis of classical prescription Qianghuo Shengshi Standard Decoction by UHPLC-Q Exactive Orbitrap MS].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2022
Same author

Potential Defects and Improvements of Equivalent Uniform Dose Prediction Model Based on the Analysis of Radiation-Induced Brain Injury.

Frontiers in oncology·2022
Same author

Phytochemical profile of Tibetan native fruit "Medog lemon" and its comparison with other cultivated species in China.

Food chemistry·2021
Same author

Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer.

Frontiers in oncology·2021
Same author

Half-Brain Delineation for Prediction of Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.

Frontiers in oncology·2021

Related Experiment Video

Updated: Aug 17, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.6K

RNF219 Promotes Nasopharyngeal Carcinoma Progression by Activating the NF-κB Pathway.

Xiang-De Li1, Qiu-Lu Zhong1, Dan-Jing Luo1

  • 1Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, 530007, China.

Molecular Biotechnology
|December 13, 2022
PubMed
Summary

Ring finger protein 219 (RNF219) promotes nasopharyngeal carcinoma (NPC) progression by activating the NF-κB pathway. This study identifies RNF219 as a potential therapeutic target for treating NPC, a prevalent cancer in Southeast Asia.

Keywords:
InvasionMigrationNF-κB pathwayProliferationRNF219

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

10.7K
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.7K

Related Experiment Videos

Last Updated: Aug 17, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

7.6K
NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

10.7K
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Nasopharyngeal carcinoma (NPC) has a high prevalence in Southeast Asia.
  • The precise molecular mechanisms driving NPC progression remain largely unknown.
  • Identifying key regulatory factors is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of ring finger protein 219 (RNF219) in NPC.
  • To elucidate the molecular pathways regulated by RNF219 in NPC.
  • To evaluate RNF219 as a potential therapeutic target for NPC.

Main Methods:

  • Quantitative analysis of RNF219 expression in NPC tissues and cells.
  • In vitro experiments assessing the effects of RNF219 overexpression and knockdown on NPC cell behavior (invasion, migration, proliferation).
  • Investigation of RNF219's impact on the nuclear factor kappa B (NF-κB) signaling pathway, including p65 translocation and target gene expression.
  • Assessment of NF-κB pathway inhibition in RNF219-overexpressing cells.

Main Results:

  • RNF219 expression was significantly upregulated in NPC tissues and cells.
  • RNF219 overexpression enhanced NPC cell invasion, migration, and proliferation.
  • RNF219 activated the NF-κB pathway, evidenced by increased p65 nuclear translocation and target gene expression.
  • Inhibition of the NF-κB pathway reversed the pro-tumorigenic effects of RNF219.
  • RNF219 expression positively correlated with NF-κB pathway activity in clinical samples.

Conclusions:

  • RNF219 plays a critical role in promoting NPC progression through activation of the NF-κB pathway.
  • RNF219 represents a novel and promising therapeutic target for nasopharyngeal carcinoma.
  • Targeting RNF219 could lead to the development of new treatment strategies for NPC.